S&P 500   3,394.54 (-2.04%)
DOW   27,660.84 (-2.38%)
QQQ   280.59 (-1.46%)
AAPL   114.95 (-0.08%)
MSFT   211.55 (-2.16%)
FB   280.02 (-1.67%)
GOOGL   1,598.58 (-2.11%)
AMZN   3,205.50 (+0.03%)
TSLA   418.28 (-0.56%)
NVDA   534.00 (-1.77%)
BABA   307.58 (-0.76%)
CGC   18.73 (-5.07%)
GE   7.42 (-2.75%)
MU   52.08 (-1.46%)
AMD   82.34 (+0.46%)
T   27.29 (-1.91%)
F   8.03 (-1.59%)
ACB   4.44 (-5.13%)
GILD   59.48 (-2.15%)
NFLX   484.34 (-0.81%)
NIO   26.38 (-2.87%)
BA   161.30 (-3.62%)
DIS   124.52 (-2.98%)
S&P 500   3,394.54 (-2.04%)
DOW   27,660.84 (-2.38%)
QQQ   280.59 (-1.46%)
AAPL   114.95 (-0.08%)
MSFT   211.55 (-2.16%)
FB   280.02 (-1.67%)
GOOGL   1,598.58 (-2.11%)
AMZN   3,205.50 (+0.03%)
TSLA   418.28 (-0.56%)
NVDA   534.00 (-1.77%)
BABA   307.58 (-0.76%)
CGC   18.73 (-5.07%)
GE   7.42 (-2.75%)
MU   52.08 (-1.46%)
AMD   82.34 (+0.46%)
T   27.29 (-1.91%)
F   8.03 (-1.59%)
ACB   4.44 (-5.13%)
GILD   59.48 (-2.15%)
NFLX   484.34 (-0.81%)
NIO   26.38 (-2.87%)
BA   161.30 (-3.62%)
DIS   124.52 (-2.98%)
S&P 500   3,394.54 (-2.04%)
DOW   27,660.84 (-2.38%)
QQQ   280.59 (-1.46%)
AAPL   114.95 (-0.08%)
MSFT   211.55 (-2.16%)
FB   280.02 (-1.67%)
GOOGL   1,598.58 (-2.11%)
AMZN   3,205.50 (+0.03%)
TSLA   418.28 (-0.56%)
NVDA   534.00 (-1.77%)
BABA   307.58 (-0.76%)
CGC   18.73 (-5.07%)
GE   7.42 (-2.75%)
MU   52.08 (-1.46%)
AMD   82.34 (+0.46%)
T   27.29 (-1.91%)
F   8.03 (-1.59%)
ACB   4.44 (-5.13%)
GILD   59.48 (-2.15%)
NFLX   484.34 (-0.81%)
NIO   26.38 (-2.87%)
BA   161.30 (-3.62%)
DIS   124.52 (-2.98%)
S&P 500   3,394.54 (-2.04%)
DOW   27,660.84 (-2.38%)
QQQ   280.59 (-1.46%)
AAPL   114.95 (-0.08%)
MSFT   211.55 (-2.16%)
FB   280.02 (-1.67%)
GOOGL   1,598.58 (-2.11%)
AMZN   3,205.50 (+0.03%)
TSLA   418.28 (-0.56%)
NVDA   534.00 (-1.77%)
BABA   307.58 (-0.76%)
CGC   18.73 (-5.07%)
GE   7.42 (-2.75%)
MU   52.08 (-1.46%)
AMD   82.34 (+0.46%)
T   27.29 (-1.91%)
F   8.03 (-1.59%)
ACB   4.44 (-5.13%)
GILD   59.48 (-2.15%)
NFLX   484.34 (-0.81%)
NIO   26.38 (-2.87%)
BA   161.30 (-3.62%)
DIS   124.52 (-2.98%)
Log in
NASDAQ:RETA

Reata Pharmaceuticals SEC Filings & 10K Form

$113.71
-3.57 (-3.04 %)
(As of 10/26/2020 11:14 AM ET)
Add
Compare
Today's Range
$113.46
Now: $113.71
$117.39
50-Day Range
$93.53
MA: $104.47
$116.15
52-Week Range
$88.17
Now: $113.71
$257.96
Volume710 shs
Average Volume361,260 shs
Market Capitalization$3.82 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.64

SEC Filings

Reata Pharmaceuticals (NASDAQ:RETA) SEC Filings

DateFilerForm TypeView
10/09/2020
8:14 AM
BlackRock Inc. (Filed by)
Reata Pharmaceuticals (Subject)
Form SC 13G/A
08/27/2020
7:00 AM
Reata Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2020
5:57 AM
Reata Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/10/2020
5:51 AM
Reata Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2020
8:16 PM
Reata Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/07/2020
5:50 AM
Reata Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2020
4:07 PM
Reata Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
06/24/2020
9:23 AM
Reata Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/22/2020
7:25 PM
McGaughy R Kent Jr (Reporting)
Reata Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2020
5:28 PM
Reata Pharmaceuticals (Issuer)
ROSE WILLIAM (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2020
3:39 PM
Nielsen Jack (Reporting)
Reata Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2020
3:34 PM
McClellan William D. Jr. (Reporting)
Reata Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2020
3:22 PM
Bass James Edward (Reporting)
Reata Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2020
8:26 AM
Reata Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/01/2020
4:27 PM
Castellanos Elaine (Reporting)
Reata Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2020
3:11 PM
Reata Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2020
5:10 AM
Reata Pharmaceuticals (Filer)
Form DEFA14A
04/29/2020
5:03 AM
Reata Pharmaceuticals (Filer)
Form DEF 14A
04/09/2020
7:53 AM
Reata Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
03/02/2020
2:02 PM
Castellanos Elaine (Reporting)
Reata Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
8:26 AM
Reata Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
01/28/2020
8:31 AM
Reata Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
01/09/2020
4:42 PM
Bass James Edward (Reporting)
Reata Pharmaceuticals (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
01/06/2020
2:12 PM
Reata Pharmaceuticals (Issuer)
WORTLEY MICHAEL D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
2:08 PM
Reata Pharmaceuticals (Issuer)
Wilson Jason Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
2:04 PM
Reata Pharmaceuticals (Issuer)
Soni Manmeet Singh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
2:00 PM
Meyer Colin John (Reporting)
Reata Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
1:56 PM
Huff James Warren (Reporting)
Reata Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
1:51 PM
Castellanos Elaine (Reporting)
Reata Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
1:47 PM
Bir Dawn Carter (Reporting)
Reata Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2020
3:15 PM
Reata Pharmaceuticals (Issuer)
Traweek James W JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2019
3:05 PM
Reata Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2019
4:30 PM
Reata Pharmaceuticals (Issuer)
Wilson Jason Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2019
4:21 PM
Meyer Colin John (Reporting)
Reata Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2019
3:17 PM
Reata Pharmaceuticals (Issuer)
Traweek James W JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2019
3:16 PM
McGaughy R Kent Jr (Reporting)
Reata Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2019
4:22 PM
Charles E. Gale Fidelity Rollover IRA (Reporting)
Evelyn P. Rose Fidelity Rollover IRA (Reporting)
Evelyn Potter Rose Survivor's Trust (Reporting)
Gale Charles E. (Reporting)
Montrose Investments GP, LLC (Reporting)
Montrose Investments I, L.P. (Reporting)
Reata Pharmaceuticals (Issuer)
Rose Evelyn P. (Reporting)
ROSE WILLIAM (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2019
10:55 AM
Reata Pharmaceuticals (Subject)
ROSE WILLIAM (Filed by)
Form SC 13D/A
11/18/2019
4:23 PM
Reata Pharmaceuticals (Issuer)
Traweek James W JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2019
4:21 PM
McGaughy R Kent Jr (Reporting)
Reata Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2019
4:20 PM
CPMG Inc (Reporting)
Reata Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2019
3:36 PM
Reata Pharmaceuticals (Filer)
Form 424B5
11/12/2019
4:49 PM
Reata Pharmaceuticals (Issuer)
WORTLEY MICHAEL D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
4:41 PM
Reata Pharmaceuticals (Issuer)
Wilson Jason Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
4:35 PM
Meyer Colin John (Reporting)
Reata Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
4:27 PM
Huff James Warren (Reporting)
Reata Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
4:22 PM
Bir Dawn Carter (Reporting)
Reata Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
4:15 PM
Reata Pharmaceuticals (Filer)
Form 424B5
11/12/2019
5:57 AM
Reata Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2019
5:50 AM
Reata Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2019
10:32 AM
Castellanos Elaine (Reporting)
Reata Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2019
3:41 PM
Castellanos Elaine (Reporting)
Reata Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2019
2:39 PM
Reata Pharmaceuticals (Issuer)
Wilson Jason Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2019
2:32 PM
Castellanos Elaine (Reporting)
Reata Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2019
3:51 PM
Castellanos Elaine (Reporting)
Reata Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2019
3:23 PM
Reata Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2019
3:03 PM
Reata Pharmaceuticals (Issuer)
Wilson Jason Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2019
2:52 PM
Castellanos Elaine (Reporting)
Reata Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2019
5:45 AM
Reata Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2019
3:47 PM
Reata Pharmaceuticals (Issuer)
Wilson Jason Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2019
5:51 AM
Reata Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2019
2:18 PM
Huff James Warren (Reporting)
Reata Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2019
1:09 PM
Reata Pharmaceuticals (Issuer)
Wilson Jason Douglas (Reporting)
Form 4/A
09/13/2019
11:26 AM
Reata Pharmaceuticals (Issuer)
Wilson Jason Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2019
2:46 PM
Castellanos Elaine (Reporting)
Reata Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2019
3:20 PM
Reata Pharmaceuticals (Issuer)
Soni Manmeet Singh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2019
3:16 PM
Reata Pharmaceuticals (Issuer)
Soni Manmeet Singh (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/22/2019
3:54 PM
Reata Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2019
2:09 PM
Reata Pharmaceuticals (Issuer)
Wilson Jason Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2019
5:50 AM
Reata Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2019
5:44 AM
Reata Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2019
12:01 PM
Reata Pharmaceuticals (Issuer)
Wilson Jason Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2019
3:06 PM
Reata Pharmaceuticals (Issuer)
Wilson Jason Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
2:02 PM
McGaughy R Kent Jr (Reporting)
Reata Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
1:18 PM
Reata Pharmaceuticals (Issuer)
ROSE WILLIAM (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
4:06 PM
Reata Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/13/2019
3:13 PM
Nielsen Jack (Reporting)
Reata Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
3:08 PM
McClellan William D. Jr. (Reporting)
Reata Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
3:05 PM
Reata Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2019
3:04 PM
Bass James Edward (Reporting)
Reata Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
12:10 PM
Castellanos Elaine (Reporting)
Reata Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
10:47 AM
Reata Pharmaceuticals (Issuer)
Wilson Jason Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2019
5:56 AM
Reata Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2019
5:49 AM
Reata Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2019
5:49 AM
Reata Pharmaceuticals (Filer)
Form DEFA14A
04/30/2019
5:04 AM
Reata Pharmaceuticals (Filer)
Form DEF 14A
04/16/2019
1:21 PM
Reata Pharmaceuticals (Issuer)
Wilson Jason Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2019
4:24 PM
Castellanos Elaine (Reporting)
Reata Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2019
2:23 PM
Reata Pharmaceuticals (Issuer)
Wilson Jason Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2019
4:32 PM
Reata Pharmaceuticals (Issuer)
Wilson Jason Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2019
4:22 PM
Reata Pharmaceuticals (Issuer)
WORTLEY MICHAEL D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2019
4:12 PM
Castellanos Elaine (Reporting)
Reata Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2019
4:05 PM
Bass James Edward (Reporting)
Reata Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
5:56 AM
Reata Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/28/2019
5:50 AM
Reata Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2019
3:22 PM
Reata Pharmaceuticals (Issuer)
Ward Keith Wayne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2019
12:50 PM
Reata Pharmaceuticals (Issuer)
Wilson Jason Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2019
5:42 AM
Reata Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
02/06/2019
4:29 PM
BlackRock Inc. (Filed by)
Reata Pharmaceuticals (Subject)
Form SC 13G/A
02/06/2019
12:01 PM
Reata Pharmaceuticals (Issuer)
Wilson Jason Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 10/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.